Published by
@ShahidNShah
@ShahidNShah
2nd Characterization & Analytical Development Summit is sheduled on 06-08 November 2024 in Boston MA. Turbocharged by increased LNP pipeline development and technological advancements with SPARTA biodiscovery raising $4.3m for their characterization technology, UPENN engineers developing CAR-T therapies, and Genevant securing a $114m deal with Tome. As the industry places a greater emphasis on later-phase assets, understanding the intricacies of LNPs and investing in analytical assays are becoming essential for ensuring market confidence.
[Read on np-characterization-analytical-development.com](https://lnp-characterization-analytical-development.com/take-part/register/)
Continue reading at lnp-characterization-analytical-development.com
November 6 to November 7, 2024
Boston
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Sep 18, 2024 at 12:51pm